Are you Dr. Nicodemus?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Unither
15walnut St, Ste300
Wellesley, MA 02481Phone+1 781-416-1506
Summary
- Dr. Christopher Nicodemus, MD is a board certified internist in Wellesley, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's HospitalFellowship, Allergy and Immunology, 1988 - 1990
- Brigham and Women's HospitalFellowship, Rheumatology, 1987 - 1988
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1987
- SUNY Upstate Medical UniversityClass of 1984
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer Start of enrollment: 2012 Jun 15
- The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer Start of enrollment: 2017 May 30
Publications & Presentations
PubMed
- 3 citationsIgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.Spas Dimitrov Markov, Thomas C. Caffrey, Kelly A. O'Connell, James A. Grunkemeyer, Simon C. Shin
Molecular Cancer Therapeutics. 2021-10-08 - 2 citationsCorrection to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/pa...Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi
Cancer Immunology, Immunotherapy. 2020-07-01 - 30 citationsFront-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II studyMolly Brewer, Roberto Angioli, Giovanni Scambia, Domenica Lorusso, Corrado Terranova
Gynecologic Oncology. 2020-03-01